Literature DB >> 4136811

Increased serum immunoglobulin levels following portacaval shunt in the normal rat.

M Keraan, O L Meyers, G H Engelbrecht, R Hickman, S J Saunders, J Terblanche.   

Abstract

Normal rats subjected to end-to-side portacaval shunt showed decreased survival and weight gain, a progressive fall in serum albumin and reciprocal rise in serum gamma globulin when compared with sham-operated controls for 12 weeks. Antibacterial lipopolysaccharide antibody was detected in significant titre at the sixth and twelfth weeks. It is suggested that the elevated levels of gamma globulin and reversal of albumin/globulin ratios noted in these animals may represent an immune response to bacterial lipopolysaccharides released into the systemic circulation as a result of the portacaval shunt. The hyperglobulinaemia of cirrhosis in human subjects may have a similar aetiology.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4136811      PMCID: PMC1413003          DOI: 10.1136/gut.15.6.468

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  An improved technique of agar-gel electrophoresis on microscope slides.

Authors:  R J WIEME
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

2.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

3.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

4.  Anti-salmonella agglutinins in chronic active liver disease.

Authors:  M Bjorneboe
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

5.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

Review 6.  Immunologic aspects of liver diseases.

Authors:  F Paronetto
Journal:  Prog Liver Dis       Date:  1970

7.  Metabolic consequences of portacaval shunting in the rat. Effects on weight, food intake, intestinal absorption and hepatic morphology.

Authors:  J P Assal; R Levrat; T Cahn; A E Renold
Journal:  Z Gesamte Exp Med       Date:  1971

8.  Experimental protein-calorie malnutrition.

Authors:  R E Kirsch; J F Brock; S J Saunders
Journal:  Am J Clin Nutr       Date:  1968-08       Impact factor: 7.045

9.  Some effects of porto-caval anastomosis in the male rat.

Authors:  M H Kyu; J B Cavanagh
Journal:  Br J Exp Pathol       Date:  1970-04

10.  [Encephalopathy of the rat with portacaval shunt: an animal model for therapeutic experiments].

Authors:  R Herz; F Robert; J Bircher
Journal:  Schweiz Med Wochenschr       Date:  1971-05-22
View more
  5 in total

1.  Antibodies to Escherichia coli in chronic liver diseases.

Authors:  A E Simjee; J M Hamilton-Miller; H C Thomas; W Brumfitt; S Sherlock
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

2.  Endotoxin-induced liver necrosis and intravascular coagulation in rats enhanced by portacaval collateral circulation.

Authors:  H Liehr; M Grün; H Thiel; D Brunswig; U Rasenack
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

3.  Hyperglobulinemia in alcoholic cirrhosis. Relationship with portal hypertension and intrahepatic portal-systemic shunting as assessed by Kupffer cell uptake.

Authors:  G Pomier-Layrargues; P M Huet; G Richer; D Marleau; A Viallet
Journal:  Dig Dis Sci       Date:  1980-07       Impact factor: 3.199

4.  Effect of mesentericocaval shunt upon globulin levels in the rat.

Authors:  G H Engelbrecht; R van Hoorn-Hickman; M Keraan; O L Meyers
Journal:  Dig Dis Sci       Date:  1981-12       Impact factor: 3.199

Review 5.  Some immunological aspects of liver function.

Authors:  D R Triger
Journal:  Yale J Biol Med       Date:  1975-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.